Considering the elevated levels of MTH1 in our tested human tumor tissues and cancer cell lines, as well as the reported significance of this protein in cancer development50, small molecule inhibitors targeting MTH1 has been recognized as a novel target-based anti-cancer strategy10,23. Here, NUDT1 is linked to neoplasm.